SCHEMBL21639656

SCHEMBL21639656

COc1ccc(CNc2ccc(C(=O)O)cc2)c(OC)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.72
CA2 P00918 3/20 0.72
HIF1A Q16665 2/20 0.57
KDM4C Q9H3R0 1/20 0.57
APLNR P35414 1/20 0.55
PPARA Q07869 1/20 0.55
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
DHFR P00374 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 2/20 0.51
AKR1C3 P42330 1/20 0.51
AKR1C2 P52895 1/20 0.51
NPC1 O15118 1/20 0.50
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.50
USP2 O75604 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27948920 0.85 APLNR (0.69) HIF1AAPLNRMEN1KMT2ADHFR
SCHEMBL21639588 0.84 CA1 (0.58) CA1CA2HIF1AKDM4CAPLNR
SCHEMBL11983159 0.83 APLNR (0.65) HIF1AAPLNRMEN1KMT2ADHFR
SCHEMBL28330968 0.82 CA1 (0.56) CA1CA2HIF1AKDM4CAPLNR
SCHEMBL4820844 0.82 HIF1A (0.72) CA1CA2HIF1AMEN1KMT2A
SCHEMBL31275112 0.81 KDM4C (0.57) CA1CA2KDM4CAPLNRMEN1
SCHEMBL15400259 0.80 APLNR (0.61) HIF1AAPLNRMEN1KMT2ADHFR
SCHEMBL8459212 0.79 RXRA (0.59) CA1CA2HIF1AMEN1KMT2A
SCHEMBL28091678 0.79 CYP1A2 (0.58) KDM4CPPARAMEN1KMT2AALDH1A1
SCHEMBL15896223 0.79 APLNR (0.63) CA1CA2HIF1AAPLNRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070747-A1 2(1H)-QUINOLINONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2021-03-11 US disclosed
EP-3604281-A1 2(1H)-QUINOLINONE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2020-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070747-A1 2(1H)-QUINOLINONE DERIVATIVE TOP2A, TOP2B, TOP1 CA1 4064/4885CA2 1393/4885HIF1A 3749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.